Key Record Dates
ClinicalTrials.gov Identifier: | NCT01295827 |
---|---|
Brief Title: | Study of Pembrolizumab (MK-3475) in Participants With Progressive Locally Advanced or Metastatic Carcinoma, Melanoma, or Non-small Cell Lung Carcinoma (P07990/MK-3475-001/KEYNOTE-001) (KEYNOTE-001) |
First Submitted : | February 10, 2011 |
First Submitted that Met QC Criteria : | February 14, 2011 |
First Posted : | February 15, 2011 (Estimate) |
Results First Submitted : | October 21, 2019 |
Results First Submitted that Met QC Criteria : | November 22, 2019 |
Results First Posted : | December 13, 2019 |
Last Update Submitted that Met QC Criteria : | November 22, 2019 |
Last Update Posted : | December 13, 2019 |